Glazier; Arnold

Patent Applications and Registrations

Patent applications and USPTO patent grants for Glazier; Arnold.The latest application filed is for "combination therapy for metastatic cancer".

Company Profile

2.7.11

Glazier; Arnold - Newton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy for Metastatic Cancer App 20220096405 - Glazier; Arnold	2022-03-31
Combination therapy for metastatic cancer Grant 11,154,520 - Glazier October 26, 2	2021-10-26
Methods For The Effective Treatment Of Metastatic Cancer App 20190240240 - Glazier; Arnold	2019-08-08
Combination For The Effective Treatment Of Metastatic Cancer In Patients App 20180338935 - GLAZIER; Arnold	2018-11-29
Methods for the Effective Treatment of Metastatic Cancer App 20180071328 - Glazier; Arnold	2018-03-15
Methods for the Effective Treatment of Metastatic Cancer App 20150265641 - Glazier; Arnold	2015-09-24
Method For The Treatment Of Proliferative Disorders Of The Eye App 20110200662 - Glazier; Arnold	2011-08-18
Exponential pattern recognition based cellular targeting compositions, methods and anticancer applications App 20070172422 - Glazier; Arnold	2007-07-26
Selective cellular targeting: multifunctional delivery vehicles, multifunctional prodrugs, use as antineoplastic drugs App 20030138432 - Glazier, Arnold	2003-07-24
Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications App 20030031677 - Glazier, Arnold	2003-02-13
Acyclovir diester derivatives App 20010012893 - Glazier, Arnold ; et al.	2001-08-09
Acyclovir diester derivatives Grant 6,214,811 - Glazier , et al. April 10, 2	2001-04-10
Phosphorous prodrugs Grant 6,140,310 - Glazier October 31, 2	2000-10-31
Phosphorus prodrugs Grant 5,789,608 - Glazier August 4, 1	1998-08-04
Tumor protease activated prodrugs of phosphoramide mustard analogs with toxification and detoxification functionalities Grant 5,659,061 - Glazier August 19, 1	1997-08-19
Phosphorous prodrugs and therapeutic delivery systems using same Grant 5,627,165 - Glazier May 6, 1	1997-05-06
Antineoplastic drugs with bipolar toxification/detoxification functionalities Grant 5,274,162 - Glazier December 28, 1	1993-12-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.